[
    [
        {
            "time": "2023-10-01",
            "original_text": "AbbVie: High-Yield Dividend Aristocrat Offering a No-Fee DRIP",
            "features": {
                "keywords": [
                    "AbbVie",
                    "High-Yield",
                    "Dividend",
                    "Aristocrat",
                    "No-Fee",
                    "DRIP"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "AbbVie: High-Yield Dividend Aristocrat Offering a No-Fee DRIP",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "Here's Why DexCom Shares Slumped 14.5% in March",
            "features": {
                "keywords": [
                    "DexCom",
                    "Shares",
                    "Slumped",
                    "14.5%",
                    "March"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Here's Why DexCom Shares Slumped 14.5% in March",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]